Probiotic and Xermelo drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Probiotic (bacillus coagulans) and Xermelo (telotristat etiprate). Common drug interactions include flatulence among females and decreased appetite among males.
The phase IV clinical study analyzes what interactions people have when they take Probiotic and Xermelo. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Probiotic?
Probiotic has active ingredients of bacillus coagulans. It is often used in irritable bowel syndrome. eHealthMe is studying from 22,462 Probiotic users. Check the latest studies of Probiotic.
What is Xermelo?
Xermelo has active ingredients of telotristat etiprate. eHealthMe is studying from 2,149 Xermelo users. Check the latest studies of Xermelo.
14 people who take Probiotic and Xermelo together, and have interactions are studied.

What are the common drug interactions of Probiotic and Xermelo, by gender? *:
female:
- Flatulence (flatus expelled through the anus)
- Abdominal distension
- Disease progression
- Abdominal pain
- Death
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Flushing (the warm, red condition of human skin)
- Haematochezia (passage of stools containing blood)
- Hyperhidrosis (abnormally increased sweating)
male:
- Decreased appetite
- Urinary tract infection
- Flushing (the warm, red condition of human skin)
- Limb injury
- Neoplasm malignant (cancer tumour)
- Weight decreased
- Fatigue (feeling of tiredness)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Suicidal ideation
- Urine output increased
What are the common drug interactions of Probiotic and Xermelo, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Blood glucose increased
- Blood triglycerides increased
- Colitis (inflammation of colon)
- Decreased appetite
- Diarrhoea
- Flushing (the warm, red condition of human skin)
- Neoplasm malignant (cancer tumour)
- Weight decreased
60+:
- Flatulence (flatus expelled through the anus)
- Abdominal distension
- Hyperhidrosis (abnormally increased sweating)
- Nasopharyngitis (inflammation of the nasopharynx)
- Oedema peripheral (superficial swelling)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Presyncope
- Pulmonary congestion (congestion in the lungs)
- Suicidal ideation
- Surgery
What are the existing conditions these people have? *
- Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 9 people, 64.29%
- Neuroendocrine Tumor: 2 people, 14.29%
- Skin Blushing/flushing (a sudden reddening of the face, neck): 1 person, 7.14%
- Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 7.14%
- Carcinoid Tumor Pulmonary: 1 person, 7.14%
- Carcinoid Tumor Of The Small Bowel: 1 person, 7.14%
- Carcinoid Tumor: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Probiotic and Xermelo?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Probiotic and Xermelo:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Probiotic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xermelo:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Probiotic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xermelo and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on bacillus coagulans and telotristat etiprate (the active ingredients of Probiotic and Xermelo, respectively), and Probiotic and Xermelo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Biaxin and Gastrooesophageal Reflux Disease for Women aged 40-49 - 15 seconds ago
- Biaxin and Gastro-Oesophageal Reflux Disease for Women aged 40-49 - 15 seconds ago
- Biaxin and Reflux for Women aged 40-49 - 16 seconds ago
- Biaxin and Heartburn for Women aged 40-49 - 16 seconds ago
- Biaxin and Non-Cardiac Chest Pain for Women aged 40-49 - 17 seconds ago
- Biaxin and Gerds for Women aged 40-49 - 17 seconds ago
- Biaxin and Acid Reflux for Women aged 40-49 - 17 seconds ago
- Biaxin and Reflux Esophagitis for Women aged 40-49 - 18 seconds ago
- Biaxin and Pyrosis for Women aged 40-49 - 18 seconds ago
- Biaxin and Peptic Esophagitis for Women aged 40-49 - 18 seconds ago